Diligence memo · auto-generated · as of July 2, 2026

Bardavon Health Innovations, Inc.

Bardavon Health Innovations, Inc. looks under-valued against its niche peers and is quiet on financing cadence.

SourceModeled below same-niche peers while still financing on rhythm — a potential mispricing worth a closer look.

Businessfiled

Bardavon Health Innovations, Inc. operates in Healthtech, based in OVERLAND PARK.

No verified homepage on file yet — operating evidence is limited to the public record.

Capital & rounds (filed)filed

Bardavon Health Innovations, Inc. has raised $157M in disclosed capital across 7 recorded rounds, aggregated from public filings. Its latest round is modeled as Series D+ (a $100M–$400M round).

Largest single filing: $107M on 2021-10-20.

Most recent recorded round closed around 2024-04-26.

Valuation (modeled)modeled

Provath models Bardavon Health Innovations, Inc. at approximately $57M (range $28M–$81M). This is an algorithmic estimate from round sizes and same-niche peers — not a quoted or reported figure.

Read: Under-valued. Modeled value is 0.05× the median modeled value of Series D+ Healthtech companies in 2022–2024 (17 peers) — value vs value, same stage and era.

Financing rhythm & timingmixed

Historic cadence: a new round about every 17 months.

Last raise 2.2 yr ago; this sector typically re-raises about every 14 months.

Slightly overdue versus sector cadence.

The last round was 1.7× smaller than the prior — a bridge or down round.

Comparablesmixed

Capital scale ranks ahead of 97% of Healthtech peers (2138 compared).

Modeled value ranks above 65% of those peers.

Closest niche peers: Monogram Health Holdings, Inc., Lyra Health, Inc., Aledade, Inc., Clarify Health Solutions, Inc., Insightec Ltd.

Peoplefiled

24 named people on file across officers, directors and signatories.

Risks & flagsmixed

No clearly named CEO/founder/principal in the surfaced records — key-person evidence is thin.